CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice and Policy

ONCOLOGY. Vol. 26 No. 5
Pages: 1  2  
Previous
PRACTICE & POLICY 

An Oncology Perspective on the Supreme Court’s Pending Decision Regarding the Affordable Care Act

By Steven K. Stranne, MD, JD1, Matthew G. Halgren1 | May 15, 2012
1Polsinelli Shughart, PC, Washington, DC

Potential Outcomes for Oncology

In summary, this June the Court will rule on the constitutionality of the ACA’s minimum coverage requirement (assuming it moves past the Anti-Injunction Act issue) as well as the issue of the Medicaid expansion. If the Court strikes the minimum coverage requirement, the Medicaid expansion, or both, the Court will consider severability.

As a result, there are a number of permutations of rulings the Court may reach:

• The minimum coverage requirement could be stricken alone.

• The minimum coverage requirement could be stricken in combination with a small number of closely related provisions.

• The Medicaid expansion could be stricken alone (or in combination with a small number of closely related provisions).

• The entire ACA could be stricken.

• The entire ACA could be upheld.

These possibilities are discussed in greater detail below.

Minimum coverage requirement alone stricken

If the Court finds the minimum coverage requirement unconstitutional but leaves the rest of the law intact, a number of problems could arise. In particular, the Obama administration asserts that the minimum coverage requirement is necessary to properly implement the ACA’s guaranteed issue provision (which requires health insurers to accept all qualified applicants regardless of health status or preexisting conditions) and community rating provision (which prohibits varying health insurance premiums based on factors other than family size, geography, age, and tobacco use). Without the minimum coverage requirement, the administration has argued, these provisions could cause health insurance premiums to increase and the number of insured people to decrease, since people would be more likely to wait until they became ill before obtaining coverage. Although this circumstance would cause significant problems for all stakeholders in the health care industry, cancer care providers might be particularly affected by an increase in the number of uninsured patients.

The Government Accountability Office and other entities have examined policies that might replace the minimum coverage requirement if such a situation were to arise.[7] Some methods of encouraging healthy people to obtain coverage might include modifying open enrollment periods (by making them fewer and further between), imposing penalties on those who do not enroll as soon as they become eligible, and allowing for greater variation in premium rates based on enrollee age. However, it is unlikely that any combination of these changes would have as large an impact on individuals’ decisions to purchase health care insurance as the minimum coverage requirement is expected to have. In any event, the current political climate may create insurmountable challenges for Members of Congress interested in replacing the minimum coverage requirement if it alone is stricken by the Court.

Minimum coverage requirement and other key insurance reforms stricken

Alternatively, the Court could decide to strike the minimum coverage requirement and also strike a limited number of ACA provisions that are closely related to that requirement. For example, the Obama administration has argued that the community rating and guaranteed issue provisions are so inextricably linked with the minimum coverage requirement that they too would have to be stricken if the minimum coverage requirement were invalidated.

If the Court agrees with the administration on this point, it would remove desirable safeguards that protect individuals with cancer. The ACA’s existing guaranteed issue provision ensures that individuals with cancer and cancer survivors will be able to access coverage on the individual insurance market even after being diagnosed with cancer. The community rating provision prevents insurers from penalizing cancer patients and survivors with exorbitant premiums. Removing these protections would, in many cases, leave these vulnerable people in the same difficult situations they confronted prior to the ACA’s passage.

Medicaid expansion stricken

The Medicaid expansion, through which an estimated 16 million people will be added to the Medicaid roles, is a major component of the ACA’s efforts to reduce the number of uninsured Americans. If the Court finds the Medicaid expansion to be unconstitutionally coercive, the Court could allow the expansion to remain in effect for states that voluntarily accept it, or it could eliminate the expansion completely.

If the Court finds that eliminating the Medicaid expansion undercuts the minimum coverage requirement (which might leave some people with a mandate to obtain coverage but no means of doing so absent Medicaid eligibility), the Court might also invalidate the ACA’s insurance market reforms or the law in its entirety on the basis of a ruling that the Medicaid expansion is unconstitutional. It is also worth noting that, while some believe that the Medicaid expansion could be stricken in a relatively narrow manner, others argue that a ruling striking the expansion could threaten the constitutional basis of a number of other laws, including Medicaid in its current form and the Clean Air Act.

Entire law stricken

If the Court finds the minimum coverage requirement or the Medicaid expansion to be unconstitutional and decides that Congress would have intended for the entire law to be invalidated absent the offending provision, a number of important protections that are of particular interest to the oncology community and are relatively unrelated to the disputed sections of the ACA would be lost. For example, the ACA:

• Eliminates annual and lifetime benefit limits, which are particularly problematic for cancer patients, cancer survivors, and other individuals with conditions that are expensive to treat.

• Prohibits insurance companies from rescinding coverage except in cases of fraud or intentional misrepresentation of material fact. Prior to enactment of the ACA, there were concerns that some insurance companies investigated beneficiaries who had recently been diagnosed with cancer or another costly disease in order to identify undisclosed conditions that would provide grounds for cancelling coverage.

• Requires Medicare, Medicaid, and private insurers to cover a variety of preventive services, including many cancer screenings, often without cost sharing.

• Requires health insurers to cover the routine patient costs associated with participation in clinical trials for the treatment of cancer and other life-threatening diseases.

These are just a sampling of the protections that would be eliminated if the entire ACA were invalidated.

Entire law stands

If the Court decides that the provisions it is considering do not violate the Constitution, all of the ACA reforms that have been discussed over the last several years will remain in place. The federal government is still working to implement the ACA as originally scheduled by soliciting comments and issuing regulations on the law’s numerous programs.

Conclusion

A number of media reports of the ACA’s week at the Supreme Court attempted to extrapolate from the justices’ questions how they were likely to rule on these important issues. Although some observers were surprised that certain justices’ statements seemed to signal reluctance to rule the law constitutional, forecasting Supreme Court decisions is a highly speculative endeavor. As a practical matter, many states and businesses are operating under the assumption that the law will stand, at least with regard to ACA deadlines approaching in the near term.

Although this article has not touched on every nuance relevant to the Court’s consideration of the ACA, we hope this discussion will assist the oncology community in contextualizing the oral arguments and understanding how each of the Court’s potential rulings may impact cancer patients and cancer care professionals. Regardless of how the Court rules, its opinion will provide a clearer picture of how the federal government may interact with the health care industry in years to come.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES

1. Pub L No. 111-148.

2. Pub L No. 111-152.

3. Florida v. US Dept of Health & Human Servs., 648 F.3d 1235 (11th Cir. 2011).

4. Seven-Sky v. Holder, 661 F.3d 1 (DC Cir. 2011).

5. Alderson Reporting Company. Transcript of Case No. 11-398 Official – Subject to Final Review. SupremeCourt.gov. Available from: http://www.supremecourt.gov/oral_arguments/argument_transcripts/11-398-Tuesday.pdf. Accessed April 10, 2012.

6. Alderson Reporting Company. Transcript of Case No. 11-400 Official – Subject to Final Review. SupremeCourt.gov. Available from: http://www.supremecourt.gov/oral_arguments/argument_transcripts/11-400.pdf. Accessed April 10, 2012.

7. Dicken JE. Private health insurance coverage: expert views on approaches to encourage voluntary enrollment. Washington, DC: United States Government Accountability Office; 2011.


 
RELATED CONTENT

How the Sequester Cuts Are Harming Oncology
ONCOLOGY,  May 15, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
US Cancer Organizations Say Medicare Cuts Will Negatively Impact Cancer Patients
April 29, 2013
Oncologists Hope Congress Will Exempt Cancer Drugs From Sequester Cuts
April 27, 2013
Groups Issue New Social Media Guidelines for Physicians
April 26, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Health Care
Evidence on Health Care
Guidelines on Health Care
Patient Education on Health Care
Clinical Trials on Health Care
Practical Articles on Health Care
Research and Reviews on Health Care
All "Health Care" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy